Dr. Steve Quay, Atossa Genetics (ATOS) Chairman & CEO
- Apr 03, 2018
Steven Quay Md, PhD
Chairman and CEO
“Atossa’s intraductal technology was invented by Dr. Love and subsequently acquired by Atossa. We are honored that Dr. Love has agreed to work with us on this important new study. This work begins as Atossa increases its corporate focus on its proprietary Endoxifen for the reduction of mammographic breast density.” READ the complete story here.